RS49607B - Benzonaftiridini kao bronhijalni terapeutici - Google Patents

Benzonaftiridini kao bronhijalni terapeutici

Info

Publication number
RS49607B
RS49607B YUP-194/99A YU19499A RS49607B RS 49607 B RS49607 B RS 49607B YU 19499 A YU19499 A YU 19499A RS 49607 B RS49607 B RS 49607B
Authority
RS
Serbia
Prior art keywords
alkoxy
hydroxyl
cycloalkylmethoxy
cycloalkoxy
alkyl
Prior art date
Application number
YUP-194/99A
Other languages
English (en)
Inventor
Beate Gutterer
Hermann Amschler
Wolf-Rudiger Ulrich
Thomas Martin
Thomas Bar
Armin Hatzellmann
Karl Sanders
Rolf Beume
Hildegard Boss
Dietrich Hafner
Hans-Peter Kley
Karl-Joseph Goebl
Dieter Flockerzi
Original Assignee
Altana Pharma Ag.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag., filed Critical Altana Pharma Ag.,
Publication of YU19499A publication Critical patent/YU19499A/sh
Publication of RS49607B publication Critical patent/RS49607B/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

jedinjenja formule I u kojoj R1 jeste 1-4C-alkil, R2 jeste hidroksil, 1-4C-alkoksi, 3-7C-cikloalkoksi, 3-7C-cikloalkilmetoksi ili 1-4C-alkoksi, koji je potpuno ili pretežno supstituisan fluorom, R3 jeste hidroksil, 1-4C-alkoksi, 3-7C-cikloalkoksi, 3-7C-cikloalkilmetoksi ili 1-4C-alkoksi, koji je potpuno ili pretežno supstituisan fluorom, ili, u kojoj R2 i R3 zajedno označavaju 1-2C-alkelendioksi grupu, R4 jeste fenil radikal supstituisan sa R5 i R6, ge R5 jeste vodonik, hidroksil, halogen, nitro grupa, 1-4C-alkil, trifluorometil ili 1-4C-alkoksi, R6 jeste CO-R7 ili CO-R8, gde R7 jeste hidroksil, 1-8C-alkoksi, 3-7C-cikloalkoksi ili 3-7C-cikloalkilmetoksi, a R8 jeste N(R81) R82, gde R81 i R82 nezavisno jedan od drugoga jeste vodonik, 1-7C-alkil, 3-7C-cikloalkil ili 3-7C-cikloalkilmetil, ili gde R81 i R82 zajedno i uključujući atom azota za koji su oba vezana, jesu 1-pirolidinil, 1-piperidil, 1-heksahidroazepinil ili 4-morfolinil radikal, I soli tih jedinjenja. Prijava sadrži još 9 patentnih zahteva.
YUP-194/99A 1996-11-11 1997-11-05 Benzonaftiridini kao bronhijalni terapeutici RS49607B (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19646298 1996-11-11
EP96118188 1996-11-13
DE19739056 1997-09-05

Publications (2)

Publication Number Publication Date
YU19499A YU19499A (sh) 2001-09-28
RS49607B true RS49607B (sr) 2007-06-04

Family

ID=27216810

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-194/99A RS49607B (sr) 1996-11-11 1997-11-05 Benzonaftiridini kao bronhijalni terapeutici

Country Status (31)

Country Link
US (1) US6008215A (sr)
EP (1) EP0937074B1 (sr)
JP (1) JP4223075B2 (sr)
KR (1) KR100484045B1 (sr)
CN (1) CN1090188C (sr)
AT (1) ATE234300T1 (sr)
AU (1) AU733129B2 (sr)
BG (1) BG63695B1 (sr)
BR (1) BR9713338B1 (sr)
CA (1) CA2270964C (sr)
CY (1) CY2476B1 (sr)
CZ (1) CZ288752B6 (sr)
DE (1) DE69719778T2 (sr)
DK (1) DK0937074T3 (sr)
EA (1) EA001551B1 (sr)
EE (1) EE03829B1 (sr)
ES (1) ES2195189T3 (sr)
GE (1) GEP20012390B (sr)
HK (1) HK1022151A1 (sr)
HU (1) HU226981B1 (sr)
ID (1) ID22042A (sr)
IL (1) IL129054A (sr)
NO (1) NO312764B1 (sr)
NZ (1) NZ334976A (sr)
PL (1) PL189641B1 (sr)
PT (1) PT937074E (sr)
RS (1) RS49607B (sr)
SI (1) SI0937074T1 (sr)
SK (1) SK283269B6 (sr)
TR (1) TR199900856T2 (sr)
WO (1) WO1998021208A1 (sr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE234301T1 (de) 1998-05-05 2003-03-15 Altana Pharma Ag Neue benzonaphtyridin-n-oxide
US6436952B1 (en) 1998-08-31 2002-08-20 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzonaphthyridine-N-oxides comprising a PDE3 and PDE4 inhibiting activity
IT1303272B1 (it) 1998-10-29 2000-11-06 Zambon Spa Derivati triciclici inibitori della fosfodiesterasi 4
AU2107700A (en) 1999-01-15 2000-08-01 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenanthridine-n-oxides with pde-iv inhibiting activity
JP2002534506A (ja) 1999-01-15 2002-10-15 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング Pde−iv抑制作用を有する多重に置換された6−フェニルフェナントリジン
SI1147103T1 (en) 1999-01-15 2005-10-31 Altana Pharma Ag Phenantrhridine-n-oxides with pde-iv inhibiting activity
ATE312081T1 (de) * 1999-01-15 2005-12-15 Altana Pharma Ag 6-phenylphenanthridine mit pde-iv hemmender wirkung
SI1212089T1 (sl) 1999-08-21 2006-08-31 Altana Pharma Ag Sinergisticna kombinacija roflumilasta in salmeterola
NL1017973C2 (nl) * 2000-05-10 2002-11-08 Tristem Trading Cyprus Ltd Inrichting.
CA2438717C (en) * 2001-02-21 2011-08-30 Altana Pharma Ag 6-phenylbenzonaphthyridines
US6479493B1 (en) 2001-08-23 2002-11-12 Cell Pathways, Inc. Methods for treatment of type I diabetes
EP1581533A2 (en) * 2002-08-17 2005-10-05 ALTANA Pharma AG Novel benzonaphthyridines
EP1537109B1 (en) * 2002-09-04 2007-04-18 ALTANA Pharma AG Novel benzonaphthyridines
US7470704B2 (en) * 2002-09-04 2008-12-30 Nycomed Gmbh Benzonaphthyridines
KR101152488B1 (ko) 2004-03-03 2012-07-02 니코메드 게엠베하 신규 히드록시-6-헤테로아릴페난트리딘 및 pde4 억제제로서의 이의 용도
AR049419A1 (es) * 2004-03-03 2006-08-02 Altana Pharma Ag Hidroxi-6-fenilfenantridinas sustituidas con heterociclilo
WO2005087745A1 (en) * 2004-03-10 2005-09-22 Altana Pharma Ag Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
EP1732925A1 (en) * 2004-03-17 2006-12-20 Altana Pharma AG Novel n-(alkoxyalkyl)carbamoyl- substituted 6-phenyl-benzonaphthyridine derivatives and their use as pde3/4 inhibitors
ES2365926T3 (es) * 2004-09-08 2011-10-13 Nycomed Gmbh 3-oxa-10-aza-fenantrenos como inhibidores de pde4 o pde3/4.
US7589205B2 (en) * 2004-09-08 2009-09-15 Nycomed Gmbh 3-thia-10-aza-phenanthrene derivatives
SI1856093T1 (sl) * 2005-03-02 2010-03-31 Nycomed Gmbh Hidrokloridna sol R aR bR dimetoksipiridin il etoksi metoksi a b heksahidrofenantridin ola
JP2009512676A (ja) 2005-10-19 2009-03-26 ランバクシー ラボラトリーズ リミテッド ムスカリン性受容体アンタゴニストの医薬組成物
TW200808695A (en) * 2006-06-08 2008-02-16 Amgen Inc Benzamide derivatives and uses related thereto
JP5399905B2 (ja) * 2006-09-01 2014-01-29 センワ バイオサイエンシズ インコーポレイテッド セリン−トレオニンタンパク質キナーゼおよびparp調節因子
EP2276761B1 (en) 2008-04-23 2015-07-29 Rigel Pharmaceuticals, Inc. Carboxamide compounds for the treatment of metabolic disorders
AR079451A1 (es) 2009-12-18 2012-01-25 Nycomed Gmbh Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
CN108299429B (zh) * 2018-04-09 2021-10-08 中南大学 一类八氢苯并萘啶化合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899494A (en) * 1970-05-13 1975-08-12 Sandoz Ltd Substituted 6-phenyl benzo-naphthyridines
EP0247971A3 (en) * 1986-05-29 1990-01-17 Sandoz Ag Novel pharmaceutical compositions comprising and use of cis-6-(4-acetanilido)-8,9-dimethoxy-2-methyl-1,2,3,4,4a,10b-hexahydrobenzo[c][1,6]naphthyridin
MY105344A (en) * 1990-05-16 1994-09-30 Byk Gulden Lomberg Chemische Fabrik New sulphonyl compounds

Also Published As

Publication number Publication date
DE69719778D1 (de) 2003-04-17
BR9713338B1 (pt) 2009-12-01
US6008215A (en) 1999-12-28
CY2476B1 (en) 2005-05-03
YU19499A (sh) 2001-09-28
KR20000053100A (ko) 2000-08-25
KR100484045B1 (ko) 2005-04-20
SI0937074T1 (en) 2003-08-31
EP0937074A1 (en) 1999-08-25
DE69719778T2 (de) 2004-02-05
CA2270964A1 (en) 1998-05-22
CA2270964C (en) 2007-07-31
HU226981B1 (hu) 2010-04-28
PL333429A1 (en) 1999-12-06
ES2195189T3 (es) 2003-12-01
NO312764B1 (no) 2002-07-01
JP4223075B2 (ja) 2009-02-12
IL129054A (en) 2002-07-25
EP0937074B1 (en) 2003-03-12
AU733129B2 (en) 2001-05-10
EE03829B1 (et) 2002-08-15
GEP20012390B (en) 2001-03-25
ATE234300T1 (de) 2003-03-15
IL129054A0 (en) 2000-02-17
CN1236367A (zh) 1999-11-24
PT937074E (pt) 2003-07-31
HUP0000426A3 (en) 2001-04-28
WO1998021208A1 (en) 1998-05-22
SK62399A3 (en) 1999-10-08
BG63695B1 (bg) 2002-09-30
NO992282D0 (no) 1999-05-11
EA199900421A1 (ru) 1999-10-28
CN1090188C (zh) 2002-09-04
EA001551B1 (ru) 2001-04-23
NZ334976A (en) 2000-10-27
AU5317098A (en) 1998-06-03
PL189641B1 (pl) 2005-09-30
HUP0000426A2 (hu) 2001-02-28
DK0937074T3 (da) 2003-06-23
JP2001503442A (ja) 2001-03-13
CZ167599A3 (cs) 1999-11-17
TR199900856T2 (xx) 1999-07-21
CZ288752B6 (cs) 2001-08-15
SK283269B6 (sk) 2003-04-01
BG103310A (en) 2000-05-31
NO992282L (no) 1999-05-11
ID22042A (id) 1999-08-26
BR9713338A (pt) 2000-05-09
HK1022151A1 (en) 2000-07-28
EE9900105A (et) 1999-10-15

Similar Documents

Publication Publication Date Title
RS49607B (sr) Benzonaftiridini kao bronhijalni terapeutici
RS50519B (sr) Supstituisani derivati 8'-piri(mi)dinil-dihidrospiro- /cikloalkilamin/-pirimido/1,2-a/pirimidin-6-ona
WO2005087745A8 (en) Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
TW273510B (sr)
GB9423968D0 (en) Resolution
MX9803891A (es) Derivados de pirazol, metodo para preparar los mismos y composiciones farmaceuticas que contienen esos derivados.
SE9600683D0 (sv) Azabicyclic esters of carbamic acids useful in therapy
CA2296031A1 (en) Novel spiroazabicyclic heterocyclic compounds
ME00108B (me) DE RIVATI DIOKSAN-2-ALKILKARBAMATA, POSTUPAK ZA NJIHOVO DOBIJANJ E l PRIMENA ISTIH U TERAPEUTICIMA
DE60130562D1 (de) Azaindolderivate, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel
PT1140916E (pt) Acetais heteroarilo ciclicos
NZ336302A (en) Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia
ES2105617T3 (es) Derivados de piperacina como antagonistas de 5-ht.
UA35562C2 (uk) Похідні 7-ізоіндолінілхінолону і 7-ізоіндолінілнафтирідону
HRP20040230B1 (en) Muscarinic agonists
HRP20031091B1 (en) Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
WO2005084104A3 (en) Novel isoamido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
NO20064220L (no) Nye heterocyklylsubstituerte hydroksy-6-fenylfenantridiner og deres anvendelse som PDE4-inhibitorer
MXPA04003278A (es) Derivados de 5-metoxi-8-aril-?1,2,4?triazolo?1,5-a?piridina como antagonistas del receptor de adenosina.
ATE247660T1 (de) Furopyridinderivate und ihre therapeutische verwendung
HUP0104201A2 (hu) Benzoilszármazékok, eljárás a vegyületek előállítására és herbicidként és növényi növekedésszabályzóként történő alkalmazásuk
ATE225335T1 (de) Amide derivate als 5-ht1a liganden
BG104471A (en) Benzylidene pyrazolones, their preparation and use as herbicides
HUP0001010A2 (hu) Benzimidazol-származékok és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
GB0203804D0 (en) Compounds